The Patent Finder

Maintenance fees coming due

Pierre Fabre Medicament

16 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Nov 30, 2026. Unpaid by Jun 1, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,661,457IGF-1R Antibody-Drug-Conjugate and Its Use for the Treatment of Cancer
In force
Fee due Nov 30, 2026
Lapses if unpaid Jun 1, 2027
 · High confidence
Pierre Fabre MedicamentIn forceNov 30, 2026Jun 1, 2027High confidence
US 10,314,921Antibody-Drug-Conjugate and Its Use for the Treatment of Cancer
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
Pierre Fabre MedicamentIn forceDec 11, 2026Jun 11, 2027High confidence
US 11,673,931Immunocytokines for the Treatment of Cancer
In force
Fee due Dec 13, 2026
Lapses if unpaid Jun 14, 2027
 · High confidence
Pierre Fabre MedicamentIn forceDec 13, 2026Jun 14, 2027High confidence
US 9,120,852Novel Antibody for the Diagnosis And/Or Prognosis of Cancer
In force
Fee due Mar 1, 2027
Lapses if unpaid Sep 1, 2027
 · High confidence
Pierre Fabre MedicamentIn forceMar 1, 2027Sep 1, 2027High confidence
US 10,414,823ANTI-C10ORF54 Antibodies and Uses Thereof
In force
Fee due Mar 17, 2027
Lapses if unpaid Sep 17, 2027
 · High confidence
Pierre Fabre MedicamentIn forceMar 17, 2027Sep 17, 2027High confidence
US 10,421,818ANTI-C10ORF54 Antibodies and Uses Thereof
In force
Fee due Mar 24, 2027
Lapses if unpaid Sep 24, 2027
 · High confidence
Pierre Fabre MedicamentIn forceMar 24, 2027Sep 24, 2027High confidence
US 10,450,299Substituted Quinazoline Derivatives as DNA Methyltransferase Inhibitors
In force
Fee due Apr 22, 2027
Lapses if unpaid Oct 22, 2027
 · High confidence
Centre National de la Recherche Scientifique (CNRS), Pierre Fabre Medicament and Sapienza Universita Di RomaIn forceApr 22, 2027Oct 22, 2027High confidence
US 10,457,734IGF-1R Antibody and Its Use for the Diagnosis of Cancer
In force
Fee due Apr 29, 2027
Lapses if unpaid Oct 29, 2027
 · High confidence
Pierre Fabre MedicamentIn forceApr 29, 2027Oct 29, 2027High confidence
US 9,173,962Novel Antigen Binding Protein and Its Use as Addressing Product for the Treatment of Cancer
In force
Fee due May 3, 2027
Lapses if unpaid Nov 3, 2027
 · High confidence
Pierre Fabre MedicamentIn forceMay 3, 2027Nov 3, 2027High confidence
US 10,517,863Trilobine and Its Natural Analogs for Use as a Drug
In force
Fee due Jun 30, 2027
Lapses if unpaid Jan 3, 2028
 · High confidence
Pierre Fabre Medicament and Centre National de la Recherche Scientifique (CNRS)In forceJun 30, 2027Jan 3, 2028High confidence
6 more maintenance fees coming due in the 12 months from Nov 18, 2026 · Pro
10 of 16 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited